Rabbit monoclonal antibody (RabMAb) demonstrates larger sensitivity with out sacrificing specificity than mouse monoclonal antibody (MMAb). MMAb towards E-cadherin stain is closely utilized in distinguishing ductal carcinoma in situ (DCIS) from lobular carcinoma in situ (LCIS). We aimed to check the E-cadherin stain utilizing RabMAb vs MMAb in distinguishing DCIS from LCIS.
One hundred and seventeen in situ breast carcinomas (55 DCIS, 58 LCIS, and four DCIS and LCIS) have been studied. Sections from a consultant block of every have been stained with RabMAb [EP700Y] and MMAb [36B5]. Scanned photos of stained slides have been in contrast in tandem.
All DCIS instances (59/59) confirmed comparable staining by RabMAb and MMAb. Comparable staining was additionally noticed in all however one case of LCIS (61/62; 98%).
One case of pleomorphic LCIS confirmed principally full, weak to reasonably intense membranous staining with RabMAb and fragmented, weak membranous staining with MMAb.
NFAT Inhibitor |
4034010.1 |
Bachem |
1 mg |
EUR 328.02 |
|
NFAT Inhibitor |
H-4874.0500 |
Bachem |
0.5mg |
EUR 327.6 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
NFAT Inhibitor |
H-4874.1000 |
Bachem |
1.0mg |
EUR 544.8 |
Description: Sum Formula: C75H118N20O22S; CAS# [249537-73-3] net |
NFAT Inhibitor |
MBS5763342-10mg |
MyBiosource |
10mg |
EUR 490 |
NFAT Inhibitor |
MBS5763342-25mg |
MyBiosource |
25mg |
EUR 875 |
NFAT Inhibitor |
MBS5763342-5x25mg |
MyBiosource |
5x25mg |
EUR 3790 |
NFAT Inhibitor |
MBS3841068-10mg |
MyBiosource |
10mg |
EUR 635 |
NFAT Inhibitor |
MBS3841068-5x10mg |
MyBiosource |
5x10mg |
EUR 2845 |
Antibiotic NFAT 133 |
T125647-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
Antibiotic NFAT 133 |
T125647-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Antibiotic NFAT 133 |
NFAT EMSA Kit |
GS-0028 |
Signosis |
30 |
EUR 374.5 |
Description: Nuclear factor of activated T-cells |
NFAT-TAG-RFP |
LTV-0001-13S |
LipExoGen |
2x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAR-GFP |
LTV-0001-14S |
LipExoGen |
2x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAB-BSD |
LTV-0001-16S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAR-BSD |
LTV-0001-2S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAL-BSD |
LTV-0001-4S |
LipExoGen |
2x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAG-BSD |
LTV-0001-5S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT probe & plate |
PP-0029 |
Signosis |
96 |
EUR 113 |
NFAT-TAB-Puro |
LTV-0001-15S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAG-Puro |
LTV-0001-1S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAL-Puro |
LTV-0001-3S |
LipExoGen |
2x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-TAR-Puro |
LTV-0001-6S |
LipExoGen |
5x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-GFP-Luc-BSD |
LTV-0001-10S |
LipExoGen |
1x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-RFP-Luc-BSD |
LTV-0001-12S |
LipExoGen |
1x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-RFP-Luc-Puro |
LTV-0001-11S |
LipExoGen |
1x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT-GFP-Luc-Puro |
LTV-0001-9S |
LipExoGen |
1x10^6 |
EUR 595 |
|
Description: VSV-G |
NFAT activation molecule 1 |
AP85978 |
SAB |
1mg |
EUR 2640 |
|
NFAT activation molecule 1 |
AP86130 |
SAB |
1mg |
EUR 2640 |
|
NFAT eGFP Reporter Lentivirus |
79922 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The NFAT eGFP Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain an enhanced GFP gene driven by the NFAT response element located upstream of the minimal TATA promoter. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by examining eGFP expression._x000D_ |
NFAT inhibitor, Cell Permeable |
MBS5763976-1mg |
MyBiosource |
1mg |
EUR 325 |
NFAT inhibitor, Cell Permeable |
MBS5763976-5x1mg |
MyBiosource |
5x1mg |
EUR 1320 |
NFAM1 (NFAT Activation Molecule 1, Calcineurin/NFAT-activating ITAM-containing Protein, NFAT-activating Protein with ITAM Motif 1, CNAIP) |
MBS645002-01mL |
MyBiosource |
0.1mL |
EUR 570 |
NFAM1 (NFAT Activation Molecule 1, Calcineurin/NFAT-activating ITAM-containing Protein, NFAT-activating Protein with ITAM Motif 1, CNAIP) |
MBS645002-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2410 |
Human NFAT Protein, hFc Tag |
MBS188575-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
NFAM1 (NFAT Activation Molecule 1, Calcineurin/NFAT-activating ITAM-containing Protein, NFAT-activating Protein with ITAM Motif 1, CNAIP, bK126B4.4, FLJ40652) |
MBS645778-005mg |
MyBiosource |
0.05mg |
EUR 630 |
NFAM1 (NFAT Activation Molecule 1, Calcineurin/NFAT-activating ITAM-containing Protein, NFAT-activating Protein with ITAM Motif 1, CNAIP, bK126B4.4, FLJ40652) |
MBS645778-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2680 |
Jurkat-Lucia™ NFAT Cells |
jktl-nfat |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1289.4 |
Human NFAT Reporter Cell Line |
ABC-RC0113 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line can be used as follows: • Monitor intracellular calcium levels. • Screen for activators or inhibitors of PKC/ Ca2+ pathway. • Screen for agonists or antagonists of T cell receptors. • Control for immune checkpoint NFAT reporter cell lines. |
NFAT Leeporter HEK293 Cell Line |
MBS668864-1Vial |
MyBiosource |
1Vial |
EUR 1960 |
NFAT Leeporter HEK293 Cell Line |
MBS668864-5x1Vial |
MyBiosource |
5x1Vial |
EUR 8630 |
NFAT Leeporter RAW264.7 Cell Line |
MBS668865-1Vial |
MyBiosource |
1Vial |
EUR 1960 |
NFAT Leeporter RAW264.7 Cell Line |
MBS668865-5x1Vial |
MyBiosource |
5x1Vial |
EUR 8630 |
NFAT inhibitor, Cell Permeable aceate |
MBS5789491-10mg |
MyBiosource |
10(mg |
EUR 345 |
NFAT inhibitor, Cell Permeable aceate |
MBS5789491-1mg |
MyBiosource |
1(mg |
EUR 150 |
NFAT inhibitor, Cell Permeable aceate |
MBS5789491-5mg |
MyBiosource |
5(mg |
EUR 255 |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT inhibitor, Cell Permeable aceate |
TP1978L-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: NFAT inhibitor, Cell Permeable aceate |
NFAT Transcription Factor Regulator-1 |
HY-112778 |
MedChemExpress |
100mg |
EUR 952.4 |
Description: NFAT Transcription Factor Regulator-1 is an IL-2 synthesis inhibitor with an IC50 of 182 nM. |
NFAT Transcription Factor Regulator-1 |
MBS5753574-10mg |
MyBiosource |
10mg |
EUR 310 |
NFAT Transcription Factor Regulator-1 |
MBS5753574-1mg |
MyBiosource |
1mg |
EUR 170 |
NFAT Transcription Factor Regulator-1 |
MBS5753574-25mg |
MyBiosource |
25mg |
EUR 510 |
NFAT Transcription Factor Regulator-1 |
MBS5753574-2mg |
MyBiosource |
2mg |
EUR 200 |
NFAT Transcription Factor Regulator-1 |
MBS5753574-5mg |
MyBiosource |
5mg |
EUR 225 |
NFAT Transcription Factor Regulator-1 |
MBS3843820-100mg |
MyBiosource |
100mg |
EUR 3755 |
NFAT Transcription Factor Regulator-1 |
MBS3843820-10mg |
MyBiosource |
10mg |
EUR 685 |
NFAT Transcription Factor Regulator-1 |
MBS3843820-50mg |
MyBiosource |
50mg |
EUR 1915 |
NFAT Transcription Factor Regulator-1 |
MBS3843820-5mg |
MyBiosource |
5mg |
EUR 425 |
NFAT Transcription Factor Regulator-1 |
MBS3843820-5x100mg |
MyBiosource |
5x100mg |
EUR 16900 |
NFAT Transcription Factor Regulator-1 |
T12218-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Transcription Factor Regulator-1 |
T12218-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: NFAT Transcription Factor Regulator-1 |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-H |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-P |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
NFAT-GFP Stable HeLa Cell Line |
T6484 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
NFAT Reporter (Luc) - Jurkat Cell Line |
60621 |
BPS Bioscience |
2 vials |
EUR 2295 |
Description: The NFAT Reporter - Jurkat Cell Line contains a firefly luciferase gene under the control of the_x000D_NFAT response element stably integrated into Jurkat cells. This cell line has been validated for_x000D_response to thapsigargin, ionomycin, and phorbol 12-myristate 13-acetate (PMA). It is useful as_x000D_a control cell line for other NFAT reporter cell lines expressing various immune checkpoint_x000D_receptors. |
ICOS/NFAT Report Cell Line--Jurkat |
ABC-RC093D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of a chimeric receptor consisting human ICOS (also known as inducible T-cell costimulator or CD278, Genbank Accession #NM_012092) and the cytoplasmic domain of human CD3 zeta. |
VEGFR2/NFAT Report Cell Line- HEK293 |
ABC-RC102D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant HEK-293 cells expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human VEGFR2 (Human Vascular Endothelial Growth Factor Receptor 2; KDR, FLK1; ref seq. NM_002253.1). |
LAG3/NFAT Report Cell Line-Jurkat |
ABC-RC110D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human LAG3 (lymphocyte-activation gene 3, CD223, GenBank Accession # NM_002286). |
Jurkat-Lucia™ NFAT-CD16 Cells |
jktl-nfat-cd16 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
Jurkat-Lucia™ NFAT-CD28 Cells |
jktl-nfat-cd28 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
Jurkat-Lucia™ NFAT-CD32 Cells |
jktl-nfat-cd32 |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
TIGIT / NFAT Reporter - Jurkat Cell Line |
60538 |
BPS Bioscience |
2 vials |
EUR 10855 |
Description: Recombinant Jurkat cell line constitutively expressing a full length human TIGIT (T_x000D_cell Immunoreceptor with Immunoglobulin and ITIM domain; VSTM3), and a firefly luciferase_x000D_gene under the control of nuclear factor of activator T cells (NFAT) response element. Both_x000D_TIGIT and NFAT constructs have been stably integrated into Jurkat cells. TIGIT expression has_x000D_been confirmed by Western Blot, and TIGIT-specific NFAT response has been validated using a_x000D_TIGIT ligand, CD155 (PVR). |
Human NFAT Reporter Cell Line– HEK293 |
ABC-RC0111 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line is derived from HEK293. This reporter cell line is an ideal product to monitor the blogical ativity |
Human NFAT Reporter Cell Line–RAW264.7 |
ABC-RC0112 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Reporter Cell Line is derived from RAW264.7. This reporter cell line is an ideal product to monitor the blogical ativity |
TIGIT/NFAT Report Cell Line-Jurkat |
ABC-RC112D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human TIGIT (V-set and immunoglobulin domain-containing protein 9, VSIG9, V-set and transmembrane domain-containing protein 3, and VSTM3, GenBank Accession No. NM_173799). |
pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451VA-P |
SBI |
>2 x 10^6 IFUs |
EUR 702 |
pGreenFire 2.0 NFAT reporter plasmid (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro) |
TR451PA-P |
SBI |
10 µg |
EUR 702 |
NFAT-Luciferase Stable RAW264.7 Cell Line |
T6125 |
ABM |
1x10^6 cells / 1.0 ml |
EUR 3950 |
NFAT Luciferase Reporter-HEK293 Cell Line |
RC1010 |
BosterBio |
1 Vial, Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO. |
EUR 1864.8 |
Description: The NFAT Luciferase Reporter cell line is a stably transfected HEK 293 cell line which expresses Renilla luciferase reporter gene under the transcriptional control of the Nuclear Factor of Activated T-cells (NFAT) response element, so that the cell line is designed to measure the transcriptional activity of NFAT. NFAT is a transcription factor originally found in activated T lymphocytes, and is now known to regulate not only T cell activation and differentiation but also the function of other immune cells including dendritic cells, B cells and megakaryocytes. The NFAT induction by calcium ionophore A23187 is shown in Figure 1. |
NFAT Luciferase Reporter-RAW264.7 Cell Line |
RC1011 |
BosterBio |
1 Vial, Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO. |
EUR 1864.8 |
Description: The NFAT Luciferase Reporter cell line is a stably transfected RAW264.7 cell line which expresses Renilla luciferase reporter gene under the transcriptional control of the Nuclear Factor of Activated T-cells (NFAT) response element, so that the cell line is designed to measure the transcriptional activity of NFAT. NFAT is a transcription factor originally found in activated T lymphocytes, and is now known to regulate not only T cell activation and differentiation but also the function of other immune cells including dendritic cells, B cells and megakaryocytes. The NFAT induction by calcium ionophore A23187 is shown in Figure 1. |
NFAT Luciferase Reporter Lentivirus-79579-G |
79579-G |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (hygromycin, puromycin, or G418) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-H |
79579-H |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-P |
79579-P |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
PD-1 / NFAT Reporter - Jurkat Cell Line |
60535 |
BPS Bioscience |
2 vials |
EUR 11375 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #NM_005018)._x000D_ |
Human BTLA NFAT luci Jurkat Cell Line |
E24C00271 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human CD96 NFAT luci Jurkat Cell Line |
E24C00382 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human CTLA4 NFAT luci Jurkat Cell Line |
E24C00053 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human CD226 NFAT luci Jurkat Cell Line |
E24C00430 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human VEGFR2 NFAT luci HEK293 Cell Line |
E24C00136 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human LILRB2 NFAT luci Jurkat Cell Line |
E24C00242 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human LILRB1 NFAT luci Jurkat Cell Line |
E24C00297 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Jurkat-Lucia™ NFAT-CD16-Low Cells |
jktl-nfat-cd16lo |
InvivoGen FR |
3-7 x 10e6 cells |
EUR 1670.55 |
NFAT Reporter (Luciferase) - THP-1 Cell Line |
78320 |
BPS Bioscience |
2 vials |
EUR 1810 |
Description: The NFAT reporter (Luciferase)-THP-1 cell line is designed for monitoring the NFAT (nuclear factor of activated T-cells) signaling pathway in THP-1 cells by measuring luciferase activity. It contains a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter. Upon activation by NFAT activators such as Ionomycin, endogenous NFAT transcription factors bind to the DNA response elements, inducing transcription of the luciferase reporter gene. |
Mouse NFAT activation molecule 1 ELISA Kit |
EK4618 |
SAB |
96 tests |
EUR 659 |
|
Human NFAT activation molecule 1 ELISA Kit |
MBS2882456-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4545 |
Human NFAT activation molecule 1 ELISA Kit |
MBS2882456-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 440 |
Human NFAT activation molecule 1 ELISA Kit |
MBS2882456-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2440 |
Human NFAT activation molecule 1 ELISA Kit |
MBS2882456-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 580 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS2883805-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 4630 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS2883805-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 440 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS2883805-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2480 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS2883805-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 580 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS762282-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 3900 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS762282-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 340 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS762282-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 2045 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS762282-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 455 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS9428444-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3065 |
Mouse NFAT activation molecule 1 ELISA Kit |
MBS9428444-96Tests |
MyBiosource |
96Tests |
EUR 670 |
Human NFAT Luciferase Reporter Cell Line- HeLa |
ABC-RC0023 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Luciferase Reporter Cell Line- HeLa is derived from human cervical cancer, and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Receptor Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
BTLA/NFAT - Luciferase Report Cell Line-Jurkat |
ABC-RC100D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human BTLA (B and T lymphocyte associated, B and T lymphocyte attenuator, BTLA1, CD272, GenBank Accession #NM_181780). |
CD160/NFAT - Luciferase Report Cell Line-Jurkat |
ABC-RC096D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human CD160. CD160 is a GPIanchored glycoprotein member of the Ig superfamily, also known as BY55, NK1, and NK28. GenBank Accession # NM_007053. |
NFAT Reporter (eGFP) Jurkat Recombinant Cell Line |
78384 |
BPS Bioscience |
2 vials |
EUR 2240 |
Description: Recombinant Jurkat T-cells expressing an enhanced GFP (eGFP) gene under the control of NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway can be monitored by examining eGFP expression. |
TMIGD2/NFAT Luciferase Reporter Jurkat Cell Line |
78323 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Recombinant Jurkat cell line expressing firefly luciferase under the control of an NFAT response element, and with constitutive expression of human TMIGD2 (Transmembrane and immunoglobulin domain containing 2; CD28H; NM_144615). Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
NFAT Luciferase-eGFP Reporter Jurkat Cell Line |
78662 |
BPS Bioscience |
2 vials |
EUR 2195 |
Description: Recombinant Jurkat T cells expressing both firefly luciferase and enhanced GFP (eGFP) under the control of NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway can be monitored by examining either firefly luciferase or eGFP expression. |
Human PD-1 NFAT luci Jurkat Cell Line |
E24C00016 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
VEGFR2 / NFAT Reporter - HEK293 Recombinant Cell Line |
79387 |
BPS Bioscience |
2 vials |
EUR 12205 |
Description: Recombinant HEK-293 cells expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of human VEGFR2 (Human Vascular Endothelial Growth Factor Receptor 2; KDR, FLK1; ref seq. NM_002253.1). |
ICOS/NFAT Reporter-Jurkat Recombinant Cell Line |
79668 |
BPS Bioscience |
2 vials |
EUR 10340 |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of a chimeric receptor consisting human ICOS (also known as inducible T-cell costimulator or CD278, Genbank Accession #NM_012092) and the cytoplasmic domain of human CD3 zeta._x000D_ |
Human LAG-3 NFAT luci Jurkat Cell Line |
E24C00056 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx255120-96tests |
Abbexa |
96 tests |
EUR 687.5 |
|
Human NFAT activation molecule 1 (NFAM1) ELISA Kit |
abx520337-96tests |
Abbexa |
96 tests |
EUR 687.5 |
|
Mouse Nfam1(NFAT activation molecule 1) ELISA Kit |
EM0772 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
Mouse Nfam1/ NFAT activation molecule 1 ELISA Kit |
E1020Mo |
Sunlong |
1 Kit |
EUR 543 |
|
Description: Cnaip,Calcineurin/NFAT-activating ITAM-containing protein,NFAT-activating protein with ITAM motif 1 |
Human NFAM1/ NFAT activation molecule 1 ELISA Kit |
E1735Hu |
Sunlong |
1 Kit |
EUR 515 |
|
Description: CNAIP,Calcineurin/NFAT-activating ITAM-containing protein,NFAT-activating protein with ITAM motif 1 |
Human NFAT activation molecule 1, NFAM1 ELISA KIT |
ELI-36505h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Mouse NFAT activation molecule 1, Nfam1 ELISA KIT |
ELI-38266m |
Lifescience Market |
96 Tests |
EUR 1038 |
Mouse NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9343077-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Mouse NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9343077-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Mouse NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9343077-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Mouse NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9343077-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9316574-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9316574-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9316574-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human NFAT activation molecule 1, NFAM1 ELISA Kit |
MBS9316574-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human NFAT activation molecule 1 (Nfam1)ELISA Kit |
SL3395Hu |
Sunlong |
96 Tests |
EUR 468 |
|
Human NFAT activation molecule 1 (NFAM1) ELISA Kit |
RK11503 |
Abclonal |
96T |
EUR 322.37 |
Mouse NFAT activation molecule 1 (NFAM1) ELISA Kit |
RK13386 |
Abclonal |
96T |
EUR 322.37 |
Human PD-1 / NFAT Reporter Cell Line- Jurkat |
ABC-RC0117 |
AcceGen |
1 vial |
Ask for price |
Description: Human PD-1 / NFAT Reporter Cell Line is derived from Jurkat. Application: • Screen for activators or inhibitors of PD-1 signaling in a cellular context • Characterize the biological activity of PD-1 and its interactions with ligands |
NFAT Luciferase-eGFP Reporter Lentivirus-78656-G |
78656-G |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-eGFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and eGFP cassette driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and a puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or eGFP expression. |
NFAT Luciferase-eGFP Reporter Lentivirus-78656-P |
78656-P |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-eGFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and eGFP cassette driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and a puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or eGFP expression. |
Human NKG2D&DAP10 NFAT luci Jurkat Cell Line |
E24C00249 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human CXCR4 / CD184 NFAT luci HEK293 Cell Line |
E24XHB677 |
EnoGene |
each |
EUR 1225 |
|
Description: Human |
Human LAG-3 / NFAT Reporter Cell Line-Jurkat |
ABC-RC0102 |
AcceGen |
1 vial |
Ask for price |
Description: Human LAG-3 / NFAT Reporter Cell Line is derived from Jurkat. This reporter cell line can be used to screen for activators or inhibitors of LAG-3 signaling in a cellular context and characterize the biological activity of LAG-3 and its interactions with ligands |
NFAT Reporter - Hek293 Cell Line (PKC/ Ca2+ Pathway) |
79298 |
BPS Bioscience |
2 vials |
EUR 2140 |
Description: The NFAT Reporter - Hek293 cell line contains a firefly luciferase gene under the control of NFAT response element stably integrated into Hek293 cells. This cell line is validated for the response to the stimulation of phorbol 12-myristate 13-acetate (PMA) with ionomycin. |
Woodchuck PD-1/NFAT Report Cell Line-Jurkat |
ABC-RC101D |
AcceGen |
1 vial |
Ask for price |
Description: Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements with constitutive expression of woodchuck (groundhog, Marmota monax) PD-1 (Programmed Cell Death 1, PDCD1, SLEB2, CD279, GenBank Accession #HQ403652). |
ELISA Kit for Human NFAT activation molecule 1 |
E3904h |
EIAab |
96T |
EUR 396 |
ELISA Kit for Mouse NFAT activation molecule 1 |
E3904m |
EIAab |
96T |
EUR 396 |
Human NFAT Luciferase Reporter Cell Line- NIH 3T3 |
ABC-RC0025 |
AcceGen |
1 vial |
Ask for price |
Description: Human NFAT Luciferase Reporter Cell Line- NIH 3T3 is derived from mouse fibroblast, and stably express firefly luciferase reporter gene under the control of NFAT response element. This cell line is an ideal cellular model for monitoring the activation of Calcium Signaling Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
Recombinant Mouse NFAT activation molecule 1 (Nfam1), partial |
MBS1395901-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 995 |
Recombinant Mouse NFAT activation molecule 1 (Nfam1), partial |
MBS1395901-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1220 |
Recombinant Mouse NFAT activation molecule 1 (Nfam1), partial |
MBS1395901-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 995 |
Recombinant Mouse NFAT activation molecule 1 (Nfam1), partial |
MBS1395901-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1220 |
Recombinant Mouse NFAT activation molecule 1 (Nfam1), partial |
MBS1395901-1mgEColi |
MyBiosource |
1mg(E-Coli) |
EUR 1400 |
Recombinant Human NFAT activation molecule 1 (NFAM1), partial |
MBS1405089-005mgBaculovirus |
MyBiosource |
0.05mg(Baculovirus) |
EUR 995 |
Recombinant Human NFAT activation molecule 1 (NFAM1), partial |
MBS1405089-005mgMammalianCell |
MyBiosource |
0.05mg(Mammalian-Cell) |
EUR 1220 |
Recombinant Human NFAT activation molecule 1 (NFAM1), partial |
MBS1405089-05mgEColi |
MyBiosource |
0.5mg(E-Coli) |
EUR 995 |
Recombinant Human NFAT activation molecule 1 (NFAM1), partial |
MBS1405089-05mgYeast |
MyBiosource |
0.5mg(Yeast) |
EUR 1220 |
Consistently higher staining high quality was noticed in slides stained by RabMAb vs MMAb. RabMAb and MMAb towards E-cadherin have been diagnostically equal aside from one case the place RabMAb might have led to diagnostic misinterpretation.
However, the not insignificant value financial savings and simpler interpretation utilizing RabMAb might justify the chance of misinterpretation of elevated staining in uncommon instances, largely avertable with correct coaching.